Dotmatics

Dotmatics is a developer of research and development software that aims to empower scientists throughout the research process. The company provides an enterprise platform that connects science, data, and decision-making, enhancing efficiency and accelerating innovation. Its software enables scientists and students to analyze data effectively, create 2D graphs, and simplify various tasks related to data analysis, statistics, and graphing. By offering tools tailored to the needs of researchers, Dotmatics facilitates a more streamlined approach to scientific inquiry and development.

Thomas Swalla

CEO and Board Member

15 past transactions

Virscidian

Acquisition in 2024
Virscidian is a technology company that specializes in developing custom analytical software solutions tailored to fit natural laboratory workflows. Its primary offerings include scientific analytical desktop and enterprise software designed to automate data processing for chromatography and mass spectrometry. The company's software suite manages complex laboratory workflows using powerful data analysis algorithms and an open architecture, thereby enhancing productivity in biopharmaceutical and agricultural value chains.

BioGlyph

Corporate Round in 2024
BioGlyph is a biotechnology software developer focused on accelerating and enhancing the discovery and development of biologics. Its proprietary platform offers user-friendly design tools, agnostic registration, and modern data labeling, facilitating collaboration and innovation in the biologics field.

EasyPanel

Acquisition in 2024
EasyPanel is a technology company that develops software for the pharmaceutical industry. Its core product is a flow cytometry panel design software, which uses a proprietary algorithm to suggest optimized panel configurations based on instrument settings, antigen expression levels, and product availability. Users can edit these suggestions, access product reviews, and receive gating strategy recommendations.

M-Star Simulations

Acquisition in 2024
M-Star Simulations is a software company that focuses on the development of computational fluid dynamics software tailored for the chemical, biopharmaceutical, and energy sectors. The company provides tools that facilitate the simplified setup and execution of complex fluid dynamics simulations. This enables users to optimize engineering and biological processes in a simulated environment, allowing for enhanced decision-making and efficiency before actual implementation in the physical world. By offering these advanced simulation capabilities, M-Star Simulations supports industries in improving their operational effectiveness and innovation.

SoftGenetics

Acquisition in 2023
SoftGenetics develops software analysis tools tailored for genetic researchers and clinicians, addressing the challenges faced in genetic analysis. Its product lineup includes Mutation Surveyor, which identifies DNA variants from Sanger sequencing traces; NextGENe, a tool that refines and extends short sequence reads; GeneMarker, designed for genotyping with user-friendly defaults to streamline setup; and specialized software for forensic profiling and image analysis. Additionally, CGH Explorer assists in detecting genomic regions with copy number alterations. The company's solutions are aimed at enhancing sensitivity and detail in genetic testing, while minimizing false-positive rates, thereby offering researchers and clinicians effective and accessible analysis options.

Omiq

Acquisition in 2021
Omiq is a developer of a modern cytometry analysis platform that integrates machine learning with traditional analytical methods. The platform offers a flexible, modular workflow, allowing researchers to conduct their entire analysis from raw data to statistical significance within a single software environment. It combines users' expertise with advanced computational techniques and visualizations, facilitating deeper insights from complex data. The platform also includes a wide range of customizable high-parameter analysis algorithms that can be easily imported and updated, enabling researchers to effectively identify drug or therapeutic interactions by tracking biomarkers in laboratory samples.

Protein Metrics

Acquisition in 2021
Protein Metrics is a software company based in Cupertino, California, that specializes in the analysis of mass spectrometry, chromatography, and capillary electrophoresis data. Founded in 2011, the company develops innovative software tools aimed at protein characterization, addressing the evolving needs of researchers in the life sciences. Its unique algorithms are designed to reduce ambiguity, enhance reproducibility, and eliminate variability across laboratories, thereby facilitating clearer scientific insights. This focus on precision aids researchers and laboratories in the development of new diagnostics and therapeutics, supporting advancements in biotherapeutics and protein analysis.

LabArchives

Acquisition in 2021
LabArchives offers a web-based software solution for the storage, organization, sharing, and publishing of scientific data, serving as more than just an Electronic Laboratory Notebook (ELN). It functions as a collaborative platform that enables research scientists to manage and document their data effectively. The cloud-based application supports secure collaboration, automates data capture, and enhances workflows, thereby improving overall lab efficiency. LabArchives also provides a locally installed version of its software and offers a special Student Edition for high school and undergraduate students, promoting accessibility and education in scientific research. The platform is utilized by scientists globally as a comprehensive information hub for research labs.

De Novo Software

Acquisition in 2021
De Novo Software is a company specializing in flow cytometry data analysis solutions, primarily known for its product FCS Express, which is recognized as one of the fastest-growing tools in the industry. The software aims to facilitate the analysis of flow cytometry data, bridging the gap between image cytometry and actionable results. De Novo’s custom data analysis solutions support scientists and researchers throughout the drug development pipeline, enabling them to efficiently extract insights from raw data in a timely manner.

Biobright

Acquisition in 2020
BioBright LLC is a scientific lab data automation company based in Boston, Massachusetts, established in 2013. Dedicated to advancing data-centric research, BioBright develops solutions that facilitate the automation of data collection from both internal and external sources. The company's platform allows scientists to standardize and analyze critical experimental data, ensuring that validation and integrity checks are incorporated into the process. As of June 30, 2020, BioBright operates as a subsidiary of Dotmatics Limited, continuing its mission to create a smarter laboratory environment through innovative automation technologies.

nQuery

Acquisition in 2020
nQuery is a search engine for your data.

Cytapex Bioinformatics

Acquisition in 2020
Cytapex Bioinformatics Inc. is a bioinformatics contract research organization based in Burnaby, Canada, that specializes in developing automated data analysis pipelines for cytometry data. Since its incorporation in 2016, Cytapex has focused on providing expert consulting services in data management, quality control, and data analysis. The company offers customized solutions for gating and biomarker discovery, tailored for complex panels used in clinical trials and diagnostics. Its algorithms are designed to deliver rapid, robust, and reproducible data-driven results, enabling clients to demonstrate the feasibility of automated analysis, identify low-quality samples, and assess dimly expressed biomarkers. As of May 2020, Cytapex operates as a subsidiary of Insightful Science, LLC.

SnapGene

Acquisition in 2019
SnapGene is a software developer that specializes in providing solutions for molecular biology procedures, including DNA cloning and PCR. The company's software allows researchers to efficiently plan, visualize, document, and share their workflows, which helps reduce errors and save time in experimental planning. By facilitating the management of biological data and procedures, SnapGene enhances collaboration among researchers and streamlines the overall research process.

Geneious

Acquisition in 2019
Geneious is an applied bioinformatics company that offers a software platform designed for the biopharmaceutical industry. This platform provides a comprehensive suite of tools for analyzing, interpreting, and applying molecular sequence data. By delivering scalable data management and computational capabilities, Geneious enables organizations to enhance their operational efficiencies and expedite the drug discovery process.

GraphPad Software

Acquisition in 2017
GraphPad Software, Inc. is a company that specializes in developing software tailored for the international scientific community. Founded in 1989 and based in La Jolla, California, GraphPad offers a range of products designed to assist laboratory researchers in data analysis and visualization. Its flagship product, GraphPad Prism, addresses the data handling needs of researchers, while GraphPad InStat provides a step-by-step approach to data analysis. Additionally, GraphPad StatMate aids in determining necessary sample sizes, and GraphPad QuickCalcs is an online tool for various calculations, including radioactivity and statistical tests. The company’s software solutions are created by scientists for scientists, aiming to simplify the complexities of data analysis and enhance the research process.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.